OpenAI advances recursive AI; new startup pursues self-improving systems amid leaked experimental model names.

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Effective duration estimates how much the price of a bond with embedded options will change when interest rates shift, focusing on duration as a tool for managing interest rate risk. Effective ...

Abstract: In Part II, both skin and proximity effects in multisolid and hollow conductor arrays are accurately predicted over an ultrawide frequency range. This is accomplished through the development ...